Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

Medical device stocks

Ready to invest in the health product industry? Consider these 9 stocks.

The best medical device stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

How to buy medical device stocks

Sign up with an online broker or platform to invest in one of more of these medical device stocks.

  1. Compare share trading platforms. Use our comparison table to narrow down top brokers by fees and bonuses.
  2. Open and fund your brokerage account. You’ll need personal and financial details, like your contact and bank information.
  3. Search for the stock you're interested in. Find the stock by name or ticker symbol, like ABT or ABMD.
  4. Decide on how many to buy. Some brokers will allow you to purchase fractional shares, while others require you to purchase whole shares.
  5. Choose an order type. Invest in the medical device stocks now with a market order or use a limit order to delay your purchase until the stock reaches your desired price.
  6. Buy the stock. Tap or click the Buy button on your brokerage account. Once you’ve invested in the health product industry, track how your stock performs to decide when it’s time to sell.

Take a deeper dive into medical device stocks

We round up a selection of stocks in or related to the health product industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

1. Abbott Laboratories (ABT)

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Abbott Laboratories stock opened the day at $121.00 after a previous close of $121.09. The latest price was $120.98 (25 minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD40.2 billion and employs 109,000 staff.

  • Market capitalization: $215,155,130,368
  • P/E ratio: 34.1099
  • PEG ratio: 2.9903

Back to top


2. Abiomed (ABMD)

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients.

Abiomed stock opened the day at $324.81 after a previous close of $324.81. The latest price was $327.14 (25 minute delay). Abiomed is listed on the NASDAQ, has a trailing 12-month revenue of around USD$847.5 million and employs 1,725 staff.

  • Market capitalization: $14,728,509,440
  • P/E ratio: 65.751
  • PEG ratio: 2.75

Back to top


3. Align Technology (ALGN)

Align Technology, Inc. , a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

Align Technology stock opened the day at $675.60 after a previous close of $676.98. The latest price was $695.80 (25 minute delay). Align Technology is listed on the NASDAQ, has a trailing 12-month revenue of around USD$2.8 billion and employs 18,975 staff.

  • Market capitalization: $53,573,894,144
  • P/E ratio: 117.4701
  • PEG ratio: 3.7789

Back to top


4. Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery.

Edwards Lifesciences Corporation stock opened the day at $113.38 after a previous close of $111.62. The latest price was $112.27 (25 minute delay). Edwards Lifesciences Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$4.5 billion and employs 14,900 staff.

  • Market capitalization: $69,464,825,856
  • P/E ratio: 82.8354
  • PEG ratio: 2.874

Back to top


5. Boston Scientific Corporation (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.

Boston Scientific Corporation stock opened the day at $45.19 after a previous close of $45.32. The latest price was $45.60 (25 minute delay). Boston Scientific Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$11.2 billion and employs 38,000 staff.

  • Market capitalization: $64,395,636,736
  • P/E ratio: 122.8184
  • PEG ratio: 2.1584

Back to top


6. Medtronic (MDT)

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software.

Medtronic stock opened the day at $127.89 after a previous close of $127.44. The latest price was $128.17 (25 minute delay). Medtronic is listed on the NYSE, has a trailing 12-month revenue of around USD$30.1 billion and employs 90,000 staff.

  • Market capitalization: $175,620,849,664
  • P/E ratio: 49.1278
  • PEG ratio: 2.4142

Back to top


7. Penumbra (PEN)

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands.

Penumbra stock opened the day at $273.78 after a previous close of $273.20. The latest price was $276.55 (25 minute delay). Penumbra is listed on the NYSE, has a trailing 12-month revenue of around USD$592.3 million and employs 3,300 staff.

  • Market capitalization: $9,813,400,576
  • PEG ratio: -62.27

Back to top


8. Inogen (INGN)

Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Inogen stock opened the day at $66.22 after a previous close of $66.50. The latest price was $66.35 (25 minute delay). Inogen is listed on the NASDAQ, has a trailing 12-month revenue of around USD$306.9 million and employs 938 staff.

  • Market capitalization: $1,779,090,688
  • PEG ratio: 3.48

Back to top


9. SmileDirectClub (SDC)

SmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment.

SmileDirectClub stock opened the day at $7.80 after a previous close of $7.60. The latest price was $7.82 (25 minute delay). SmileDirectClub is listed on the NASDAQ, has a trailing 12-month revenue of around USD$659.6 million and employs 4,000 staff.

  • Market capitalization: $2,666,171,904

Back to top

Compare trading platforms

Compare online trading platforms by fees, asset types and bonuses to find the best for your investment in medical device stocks.
Name Product Asset types Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Robinhood
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Public
Stocks, ETFs
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Webull
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
TD Ameritrade
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
TD Ameritrade features $0 commission for online stock trades. Online options fees are $0.65/contract.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Bottom line

While it’s possible to turn a profit investing in medical device stocks, keep in mind that — like any investment — medical device stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the health product industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site